Physicians For Life - Abstinence, Abortion, Birth Control - OCs Containing Cyproterone Increase Risk of Deep Vein Thrombosis (10/01)

Sunday, February 12, 2012


	Home Birth Control Research & Statistics OCs Containing Cyproterone Increase Risk of Deep Vein Thrombosis (10/01)

Main Menu

Emergency Contraception

Legal, Federal Action

NFP - Natural Family Planning

Research & Statistics

Sterilization

Birth Control Archive

End of Life / Euthanasia

Pregnancy/Development

Related Items

Translator

Quotes to Note

A 2010 STOPP study confirmed Planned Parenthood is increasingly shifting away from performing surgical abortions and, instead, using the dangerous RU 486 abortion drug [mifepristone/mifeprex] that has been responsible for killing at least 13 women worldwide (maybe more) and injured 1,100 in the United States alone as of FDA figures from 2006.

Planned Parenthood lowered the number of surgical abortion centers by 8, in 2010, but increased its number of facilities pushing the abortion drug by 25.

The PP abortion business ended the year 2010 with a total of 321 abortion facilities with 165 doing surgical abortions and giving out the abortion drug mifepristone, and another 156 dispensing the abortion drug but not doing surgical abortions.

This represents an increase of 5.5 percent from the 304 abortion facilities it operated at the end of 2009 and, although Planned Parenthood likes to talk about the low percentage of abortions it does compared to other “services,” more than 40 percent of its centers do some type of abortion.

http://www.lifenews.com/2011/03/23/report-number-of-planned-parenthood-centers-at-25-year-low/

OCs Containing Cyproterone Increase Risk of Deep Vein Thrombosis (10/01)

ORAL CONTRACEPTIVES CONTAINING CYPROTERONE INCREASE RISK OF DEEP VEIN THROMBOSIS: four times more likely to develop deep vein thrombosis, or venous blood clots, than those taking OCs that contain levonorgestrel.

Deep vein thrombosis can cause potentially fatal pulmonary embolism if blood clots travel through the bloodstream and lodge in the lungs. The retrospective case-control study of 24,401 women ages of 16-39, 1992-1999. Of the 26 cases and 144 controls, 14 cases and 114 controls had taken OCs with levonorgestrel, and 12 cases and 30 controls had taken OCs with cyproterone.

The analysis also showed that duration of exposure did not affect risk of venous thromboembolism after cyproterone exposure (Lancet, 10/27). Cyproterone is found in "so-called third-generation" birth control pills, which contain more progestin than older versions, such as those that contain levonorgestrel [Research letter, 27Oct01, Vasilakis-Scaramozza/Jick, (Boston Univ School of Medicine) Lancet Reuters Health, 10/26; Kaiser Daily Reproductive Health Reports, 10/29]

< Prev		Next >

[ Back ]


	Home \| About Us \| Current Headlines \| Abortion \| Abstinence \| Birth Control \| End of Life / Euthanasia \| Medical Research \| Medical Students \| Population \| Position Statements \| Pregnancy/Development \| STDs \| Stem Cells & Cloning \| Contact Us \| Web Links \| Site Index \| Resources \|